Bank of America’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $192M | Buy |
1,014,800
+99,656
| +11% | +$17.4M | 0.01% | 757 |
|
|
2025
Q4 | $156M | Sell |
915,144
-52,757
| -5% | -$8.09M | 0.01% | 857 |
|
|
2025
Q3 | $128M | Sell |
967,901
-84,569
| -8% | -$10.1M | 0.01% | 1059 |
|
|
2025
Q2 | $112M | Buy |
1,052,470
+58,937
| +6% | +$6.4M | 0.01% | 1085 |
|
|
2025
Q1 | $123M | Buy |
993,533
+402,189
| +68% | +$52.5M | 0.01% | 962 |
|
|
2024
Q4 | $72.8M | Sell |
591,344
-35,641
| -6% | -$4.2M | 0.01% | 1235 |
|
|
2024
Q3 | $69.9M | Buy |
626,985
+127,078
| +25% | +$13.9M | 0.01% | 1309 |
|
|
2024
Q2 | $53.4M | Sell |
499,907
-68,055
| -12% | -$7.48M | ﹤0.01% | 1406 |
|
|
2024
Q1 | $68.4M | Buy |
567,962
+97,478
| +21% | +$11.9M | 0.01% | 1262 |
|
|
2023
Q4 | $57.9M | Sell |
470,484
-308,266
| -40% | -$38.5M | 0.01% | 1263 |
|
|
2023
Q3 | $101M | Buy |
778,750
+239,073
| +44% | +$31.9M | 0.01% | 884 |
|
|
2023
Q2 | $66.9M | Buy |
539,677
+35,205
| +7% | +$4.74M | 0.01% | 1111 |
|
|
2023
Q1 | $73.8M | Buy |
504,472
+218,893
| +77% | +$32.4M | 0.01% | 1111 |
|
|
2022
Q4 | $45.5M | Sell |
285,579
-70,478
| -20% | -$10.3M | 0.01% | 1371 |
|
|
2022
Q3 | $47.5M | Buy |
356,057
+55,367
| +18% | +$8.42M | 0.01% | 1299 |
|
|
2022
Q2 | $46.9M | Sell |
300,690
-1,261
| -0.4% | -$194K | 0.01% | 1308 |
|
|
2022
Q1 | $47M | Buy |
301,951
+47,553
| +19% | +$6.9M | ﹤0.01% | 1412 |
|
|
2021
Q4 | $32.4M | Sell |
254,398
-37,846
| -13% | -$4.97M | ﹤0.01% | 1756 |
|
|
2021
Q3 | $38.1M | Sell |
292,244
-140,896
| -33% | -$21.3M | ﹤0.01% | 1560 |
|
|
2021
Q2 | $76.9M | Buy |
433,140
+60,365
| +16% | +$10.5M | 0.01% | 1088 |
|
|
2021
Q1 | $61.3M | Buy |
372,775
+9,350
| +3% | +$1.54M | 0.01% | 1156 |
|
|
2020
Q4 | $60M | Buy |
363,425
+93,054
| +34% | +$13.9M | 0.01% | 1067 |
|
|
2020
Q3 | $38.6M | Sell |
270,371
-82,470
| -23% | -$10.2M | 0.01% | 1240 |
|
|
2020
Q2 | $38.9M | Buy |
352,841
+56,284
| +19% | +$6.22M | 0.01% | 1160 |
|
|
2020
Q1 | $29.6M | Sell |
296,557
-48,936
| -14% | -$6.33M | 0.01% | 1239 |
|
|
2019
Q4 | $51.6M | Buy |
345,493
+27,671
| +9% | +$3.77M | 0.01% | 1162 |
|
|
2019
Q3 | $40.7M | Sell |
317,822
-8,096
| -2% | -$1.09M | 0.01% | 1268 |
|
|
2019
Q2 | $46.5M | Sell |
325,918
-51,646
| -14% | -$6.94M | 0.01% | 1184 |
|
|
2019
Q1 | $54M | Buy |
377,564
+52,018
| +16% | +$6.78M | 0.01% | 1059 |
|
|
2018
Q4 | $40.4M | Sell |
325,546
-72,340
| -18% | -$10.7M | 0.01% | 1146 |
|
|
2018
Q3 | $66.9M | Buy |
397,886
+62,765
| +19% | +$10.8M | 0.01% | 923 |
|
|
2018
Q2 | $57.7M | Buy |
335,121
+121,590
| +57% | +$19.9M | 0.01% | 1002 |
|
|
2018
Q1 | $32.2M | Buy |
213,531
+23,679
| +12% | +$3.47M | 0.01% | 1384 |
|
|
2017
Q4 | $25.6M | Buy |
189,852
+31,428
| +20% | +$4.36M | ﹤0.01% | 1609 |
|
|
2017
Q3 | $23.2M | Buy |
158,424
+61,394
| +63% | +$9.28M | ﹤0.01% | 1747 |
|
|
2017
Q2 | $15.1M | Sell |
97,030
-7,277
| -7% | -$1.11M | ﹤0.01% | 1985 |
|
|
2017
Q1 | $15.1M | Sell |
104,307
-23,430
| -18% | -$3.05M | ﹤0.01% | 2016 |
|
|
2016
Q4 | $13.9M | Sell |
127,737
-129,848
| -50% | -$14.5M | ﹤0.01% | 2004 |
|
|
2016
Q3 | $31.3M | Buy |
257,585
+87,756
| +52% | +$11.8M | 0.01% | 1293 |
|
|
2016
Q2 | $24M | Buy |
169,829
+4,318
| +3% | +$637K | 0.01% | 1456 |
|
|
2016
Q1 | $21.6M | Sell |
165,511
-122,202
| -42% | -$15.2M | 0.01% | 1507 |
|
|
2015
Q4 | $40.4M | Buy |
287,713
+61,232
| +27% | +$8.49M | 0.01% | 1131 |
|
|
2015
Q3 | $30.1M | Buy |
226,481
+24,910
| +12% | +$4.29M | 0.01% | 1310 |
|
|
2015
Q2 | $35.5M | Buy |
201,571
+1,679
| +0.8% | +$302K | 0.01% | 1034 |
|
|
2015
Q1 | $34.5M | Sell |
199,892
-38,511
| -16% | -$6.61M | 0.01% | 1017 |
|
|
2014
Q4 | $39M | Sell |
238,403
-36,089
| -13% | -$5.99M | 0.01% | 973 |
|
|
2014
Q3 | $44.1M | Sell |
274,492
-153,419
| -36% | -$23.6M | 0.01% | 906 |
|
|
2014
Q2 | $62.9M | Buy |
427,911
+12,467
| +3% | +$1.73M | 0.02% | 724 |
|
|
2014
Q1 | $57.6M | Sell |
415,444
-144,102
| -26% | -$21.7M | 0.02% | 700 |
|
|
2013
Q4 | $70.8M | Sell |
559,546
-8,512
| -1% | -$881K | 0.03% | 622 |
|
|
2013
Q3 | $52.2M | Buy |
568,058
+135,824
| +31% | +$11M | 0.02% | 706 |
|
|
2013
Q2 | $29.7M | Buy |
+432,234
| New | +$26.4M | 0.01% | 962 |
|
Other funds holding JAZZ
VPM
VCM
EC
Bank of America's JAZZ Position: Q1 2026 in Review
Bank of America increased its Jazz Pharmaceuticals (JAZZ) stake by 11% in Q1 2026, buying an estimated $17.4M and bringing the position to 1,014,800 shares worth $192M. The position accounts for 0.01% of the portfolio, ranked #757.
Bank of America first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Bank of America held 1,014,800 shares of Jazz Pharmaceuticals worth $192M as of Q1 2026.
- Bank of America bought 99,656 Jazz Pharmaceuticals shares in Q1 2026, an estimated $17.4M.
- Jazz Pharmaceuticals made up 0.01% of Bank of America's portfolio in Q1 2026, its #757 holding.
- Bank of America first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.